Atezolizumab in combination with bevacizumab, paclitaxel and carboplatin for the first-line treatment of patients with metastatic non-squamous non-small cell lung cancer, including patients with EGFR mutations

Martin Reck, Geetha Shankar, Anthony Lee, Shelley Coleman, Mark McCleland, Vassiliki A. Papadimitrakopoulou, Mark A. Socinski, Alan Sandler

Research output: Contribution to journal › Article › peer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'Atezolizumab in combination with bevacizumab, paclitaxel and carboplatin for the first-line treatment of patients with metastatic non-squamous non-small cell lung cancer, including patients with EGFR mutations'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences